LYFE CAPITAL MANAGEMENT LIMITED
LYFE CAPITAL MANAGEMENT LIMITED is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US, global and Asia investing in Healthcare, pharma-tech and health-data.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, pharma-tech, health-data
- Invests in
- US-wide, global, Asia
- Actively investing
- Yes
- Founded
- 2015
- Assets under management
- $2B
Check size not disclosed
Thesis
LYFE Capital Management Limited is a global investment firm founded in 2015, specializing in the healthcare sector. Their investment thesis focuses on high-growth potential companies within the global healthcare ecosystem, particularly those in critical supply chain assets, specialized product platforms, and next-generation R&D services. They target companies in healthcare, biotech, pharma-tech, and health-data sectors, investing from pre-seed to Series C. Their strategy involves geographic revenue expansion and bolt-on acquisitions, aiming to combine Asian cost efficiencies with U.S. innovation for cross-border opportunities. They manage capital from global institutional investors. They have facilitated over 20 IPOs and 10 M&A transactions. The firm has offices in Menlo Park, Seoul, Shanghai, Tokyo, and Singapore, with headquarters in Singapore and a significant U.S. presence in Menlo Park, California.
Common questions
Does LYFE CAPITAL MANAGEMENT LIMITED invest at the Pre-seed stage?
Yes. LYFE CAPITAL MANAGEMENT LIMITED lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
Where does LYFE CAPITAL MANAGEMENT LIMITED invest?
LYFE CAPITAL MANAGEMENT LIMITED invests in the US, global and Asia.